Australasian Leukaemia & Lymphoma Group - ALLG

Australasian Leukaemia & Lymphoma Group - ALLG For patients, this means an improved chance of cure, and better quality of life.

Since 1973 the ALLG has been pioneering life-changing blood cancer clinical trials, delivering innovative treatment options that transform the lives of those with blood cancer. The Australasian Leukaemia & Lymphoma Group (ALLG) is the only not-for-profit, collaborative clinical research group in Australia and New Zealand dedicated to finding new ways to treat blood cancers such as leukaemia, lymph

oma, myeloma and myelodysplastic syndromes. The ALLG membership includes more than 1,000 doctors, nurses, scientists and support staff across Australia and New Zealand, all of whom are looking for ways to better treat blood cancers through clinical research. By conducting national and international collaborative clinical trials at sites across Australia and New Zealand, ALLG researchers are helping to make new and more effective treatments available to people suffering from blood cancers.

It was fantastic to see so many ALLG members presenting their research at the 2025 International Conference on Malignant...
19/08/2025

It was fantastic to see so many ALLG members presenting their research at the 2025 International Conference on Malignant Lymphoma (ICML), including important updates on our lymphoma trials NHL39 POLAR BEAR, NHL37 GOlDiLOX and HD10. There was a sense of collaboration and momentum as we deepened discussions with leading international research groups and industry partners to deliver access to better lymphoma treatments across Australia and New Zealand.

These engagements reflect ALLG's role as Australasia's only not-for-profit, collaborative blood cancer clinical trials group, driving progress in the treatment of leukaemia, lymphoma and related blood diseases through independent, investigator-initiated clinical trials.

ALLG are Global Leaders with Global Impact, with over 5 decades of designing and delivering leading clinical trials to over 15,000 patients. Every approved treatment today started with a clinical trial.

Visit allg.org.au to learn more about our research and how you can support the future of blood cancer treatments.

With Spring right around the corner, it’s the perfect time to ditch the doona and reach for those trainers once again. W...
15/08/2025

With Spring right around the corner, it’s the perfect time to ditch the doona and reach for those trainers once again. Why not use the excuse of raising funds for blood cancer research as the perfect motivation to get back to your training again!

Join Team ALLG by choosing one of the many amazing challenge events around Australia and sign up to raise much needed funds for blood cancer research! Every dollar you raise goes directly to ALLG’s leading blood cancer research to find better treatments for people with leukaemia, lymphoma and myeloma. To find out more & sign up, visit: https://www.allg.org.au/support-us/team-allg/.

Clinical trials are vital in advancing new cancer treatments in blood cancers. In fact, every cancer treatment available...
13/08/2025

Clinical trials are vital in advancing new cancer treatments in blood cancers. In fact, every cancer treatment available to patients today began with a clinical trial.

ALLG clinical trials give people with blood cancers like leukaemia, lymphoma and myeloma access to new, innovative therapies that may improve survival outcomes and quality of life, with the hope for cure.

For over five decades, ALLG and our clinician members have driven impactful and life-changing clinical trials that have shaped the standard of care for blood cancers. Trials like ALLG APML5, which resulted in a new, less toxic tablet treatment for acute promyelocytic leukaemia that revolutionised therapy for this once fatal cancer. Or our AMLM26 INTERCEPT clinical trial, which is bringing molecularly targeted, precision medicine treatments to patients with acute myeloid leukaemia to keep them in remission from their cancer longer, with hope for cure.

As Australasia’s only not-for-profit, collaborative blood cancer clinical trial group, ALLG is committed to our mission of Better treatments…Better lives for all people with blood cancer.

To find out more about ALLG’s research, visit allg.org.au.

We were proud to have ALLG CEO Delaine Smith and SAC Chair Prof Judith Trotman in attendance at the recent Western NSW L...
07/08/2025

We were proud to have ALLG CEO Delaine Smith and SAC Chair Prof Judith Trotman in attendance at the recent Western NSW Local Health District (WNSWLHD) Haematology & Transfusion Conference, joining other haematology professionals from across Australia.

This event was a fantastic opportunity to hear from leading professionals and share knowledge and innovative insights into haematology, transfusion medicine and regional/rural medical care.

ALLG is a leader in clinical trial research in haematology, with over 75+ clinical trials in leukaemia, lymphoma and myeloma. Attending the WNSWLHD Conference enabled our ALLG team to connect with their peers and share learnings and expertise as we accelerate our clinical trial research and patient impact to create Better treatments…Better lives.

To find out more about ALLG’s leading blood cancer research, visit allg.org.au.

ALLG News Edition 12  is now out! At the centre of this edition is the BM12 CAST trial, led by Professor David Curtis, w...
05/08/2025

ALLG News Edition 12 is now out! At the centre of this edition is the BM12 CAST trial, led by Professor David Curtis, which is reshaping 40 years of stem cell transplant practice. Presented at EHA 2025 and published in the New England Journal of Medicine, this trial demonstrates that a simplified, less toxic conditioning regimen can triple survival rates and reduce severe complications like Graft Versus Host Disease (GVHD) in matched sibling donor stem cell transplants. This breakthrough is already being adopted in Australian hospitals and has the potential to become a new global standard of treatment.

Edition 12 also highlights ALLG’s research presence at international conferences, progress across key clinical trials, insights from our recent Scientific Meeting in Sydney and a powerful feature on an artist and blood cancer survivor Alison, whose story reminds us why ALLG's research matters.

Read Edition 12 at https://tinyurl.com/ytyjhzreto see the impact of donor-supported research and learn how you can help drive the next treatment breakthrough.


If the winter months has you wanting to gather with friends and family for some quality time, why not turn it into an op...
31/07/2025

If the winter months has you wanting to gather with friends and family for some quality time, why not turn it into an opportunity to raise vital funds for blood cancer research?

Come together with your crew to host a fun and meaningful event - you could hold a trivia or games night, a fancy dress dinner party, or whatever works best for you! Every dollar raised goes towards cutting edge clinical trials aimed at finding better treatment options for all those impacted by blood cancer. Follow the link to learn more or reach out to the team with your ideas! https://www.allg.org.au/support-us/fundraise-for-us/

Clinical trials are the driving force behind every breakthrough in blood cancer treatments. They investigate new innovat...
29/07/2025

Clinical trials are the driving force behind every breakthrough in blood cancer treatments. They investigate new innovative therapies and improve current ones to provide better outcomes and better quality of life. Clinical trials also provide patients access to cutting-edge treatments that are not yet widely available in Australia.

ALLG has been at the forefront of blood cancer clinical trial research for over 50 years. Our work continues to shape the way blood cancers are treated, not just in Australia and New Zealand, but around the world. Over the past year, we’ve supported 1,061 patients through an extensive portfolio of 75 + clinical trials in leukaemia, lymphoma & myeloma.

Visit allg.org.au to learn more about our groundbreaking research and our impact on blood cancer treatments.

Patients are at the centre of ALLG's clinical trials. From trial design and throughout the conduct of the trial, ALLG is...
24/07/2025

Patients are at the centre of ALLG's clinical trials. From trial design and throughout the conduct of the trial, ALLG is committed to listening to the voices of those who have had a lived experience to ensure patient priorities are considered and incorporated into our research.

The involvement and perspective of our Consumer Representative Panel (CRP) is essential in providing key insights to the patient experience. By working closely with our clinician researchers, they help to continuously improve patient care and move forward with new and innovative treatments for blood cancers, with the aim of finding a cure.

We greatly appreciate their contributions to our blood cancer research. Read more about Consumer Representatives and their experiences at https://www.allg.org.au/about-us/survivor-stories/.

With two young children including a 10-month-old, life was pretty busy for Rosie when she received the worst news imagin...
22/07/2025

With two young children including a 10-month-old, life was pretty busy for Rosie when she received the worst news imaginable - she had Acute Myeloid Leukaemia (AML). What followed was a difficult journey for the entire family, compounded by a global pandemic that restricted her treatment options. Despite some hiccups, Rosie was able to complete her treatment and has remained cancer free in the five years since diagnosis.

Inspired by the gratitude she felt for her medical team, Rosie signed up for 2025 City to Casino to raise vital funds for ALLG, so that more people who urgently need cutting edge treatments for their blood cancer can access them.

As she trained for the big day, Rosie was not alone. Little Charlie wanted to join his mum in running and fundraising! Rosie shares, “He had just done the cross country at school that week but ran the whole race with me!” By encouraging her loved ones to donate to their cause, Rosie and Charlie raised an incredible $1300 and had and fun and fulfilling day together at the race. Rosie says, “Charlie loved it and is already wanting to come back next year to do a longer distance!”

We can’t wait, Rosie! To join any of the Team ALLG challenge events throughout the country and raise much needed funds for blood cancer research, click here https://www.allg.org.au/support-us/team-allg/.


Thanks to your support, we're investing in the future of blood cancer research.In collaboration with the Haematology Soc...
17/07/2025

Thanks to your support, we're investing in the future of blood cancer research.

In collaboration with the Haematology Society of Australia & New Zealand (HSANZ), we are supporting the HSANZ Clinical Trials Fellowship 2026. This exciting Fellowship is now in its second year, offering $70,000 funding for an exceptional early-career researcher to embark on a focused blood cancer clinical or translational trial project. It’s a unique pathway into research that directly benefits people living with leukaemia, lymphoma, myeloma, and related blood cancers.

By supporting emerging talent, ALLG is accelerating the development of new therapies and working toward better outcomes and quality of lives for patients.

Visit allg.org.au to find out more and how you can support our programs.


A BIG thank you and congratulations to the fantastic members of Team ALLG who were out in force this past Sunday at Run ...
15/07/2025

A BIG thank you and congratulations to the fantastic members of Team ALLG who were out in force this past Sunday at Run Melbourne 2025. Smashing running PBs, fundraising for clinical trials and blood cancer research and cheering each other on was all in a day's work for Team ALLG! The team soaked up the fantastic event atmosphere and celebrated raising over $6,500 in support of cutting edge blood cancer clinical trials.

Every dollar raised goes towards a future where blood cancers like leukaemia, lymphoma and myeloma can be treated, even cured. Without any ongoing funding, ALLG relies on the generosity of our amazing community and wish to thank everyone who participated, supported and donated.

To see how you too can be a part of Team ALLG, visit https://www.allg.org.au/support-us/team-allg/.

During   2025 (6–13 July), ALLG reaffirms our commitment to improving health outcomes for Aboriginal and Torres Strait I...
10/07/2025

During 2025 (6–13 July), ALLG reaffirms our commitment to improving health outcomes for Aboriginal and Torres Strait Islander peoples. As a national not-for-profit clinical trials group, ALLG is dedicated to ensuring equitable access to blood cancer research and treatment.

Our specialist Rural & Regional Haematology Working Group facilitates access to clinical trials through vital research linkages across metropolitan, regional, rural and remote areas in Australia.

Visit allg.org.au for more information.

Address

Ground Floor, 35 Elizabeth Street
Melbourne, VIC
3121

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Australasian Leukaemia & Lymphoma Group - ALLG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Australasian Leukaemia & Lymphoma Group - ALLG:

Featured

Share

Our Story

The Australasian Leukaemia & Lymphoma Group (ALLG) is the only not-for-profit, investigator run clinical research group in Australia and New Zealand dedicated to finding new ways to treat blood cancers such as leukaemia, lymphoma, myeloma and myelodysplastic syndromes. The ALLG membership includes more than 750 doctors, nurses, scientists and professional staff across Australia and New Zealand, all of whom are looking for ways to better treat blood cancers through clinical research. By conducting national and international collaborative clinical trials at sites across Australia and New Zealand, ALLG researchers are helping to make new and more effective treatments available to people suffering from blood cancers. For patients, this means an improved chance of cure, and better quality of life.